Targets, Drugs & Biology in CNS – what’s the problem?
10 Sept 2026
Target Discovery
- AI is giving us more Targets – how will it help us unravel drug-biology complexity?
- Does humanising drug discovery improve translatability?
- Have biomarkers significantly moved the needle?
- Will balance between small molecule v other modality therapeutics shift significantly in the next 5-10 years?
- Convergence between neuroscience, inflammation, and metabolic disease – what are the opportunities?
